By now you’ve undoubtedly heard the reports that Jason Giambi failed an amphetamines test within the last year.
I can’t speak to whether that’s true or not. The Daily News had the story not my paper. Their sources were anonymous as well.
But there are a few aspects of the situation to keep in mind.
This does not necessarily increase the odds of the Yankees trying to void his contract. The Yankees would have been the first to know about a failed test. If they didn’t void his deal then, why would they do so now? They still do not appear to have grounds.
This does, however, decrease the odds of his getting traded. Not only does Giambi have a no-trade clause, but no team would want a player who could get suspended for 50 games any any point.
“Amphetamines” is a catch-all term that includes many over-the-counter products. Any one of us can go in a store right now and purchase assorted pills claiming to keep you awake and alert. Those are technically amphetamines that are banned under the agreement.
Giambi’s only punishment as a first-time offender was increased testing. A second failed test would lead to a 25-game suspension.
I will report more on this later once I get to the Bronx and hear what Brian Cashman and Joe Torre have to say along with Giambi himself.
Giambi has done plenty wrong here, no question about that. But all of the recent furor is the direct result of a conversation he had that he thought was off the record.
In terms of baseball, the question now is whether Giambi can help the Yankees win what is a very important game tonight.